Vytrus Biotech S.A. (VYT) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.047x

Based on the latest financial reports, Vytrus Biotech S.A. (VYT) has a cash flow conversion efficiency ratio of 0.047x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€225.55K ≈ $263.69K USD) by net assets (€4.75 Million ≈ $5.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vytrus Biotech S.A. - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Vytrus Biotech S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Vytrus Biotech S.A. total liabilities for a breakdown of total debt and financial obligations.

Vytrus Biotech S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vytrus Biotech S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tambun Indah Land Bhd
KLSE:5191
0.055x
Apex Biotechnology Corp
TW:1733
0.003x
Solesence, Inc. Common Stock
NASDAQ:SLSN
-0.146x
Carnaby Resources Ltd
AU:CNB
-0.074x
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
0.011x
Handok
KO:002390
0.042x
Aniplus Inc
KQ:310200
0.106x
Canadian Life Companies Split Corp
TO:LFE
0.023x

Annual Cash Flow Conversion Efficiency for Vytrus Biotech S.A. (2020–2024)

The table below shows the annual cash flow conversion efficiency of Vytrus Biotech S.A. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see Vytrus Biotech S.A. market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €7.29 Million
≈ $8.53 Million
€1.84 Million
≈ $2.16 Million
0.253x +47.95%
2023-12-31 €5.29 Million
≈ $6.19 Million
€904.39K
≈ $1.06 Million
0.171x +260.14%
2022-12-31 €4.75 Million
≈ $5.56 Million
€225.55K
≈ $263.69K
0.047x -54.97%
2021-12-31 €4.25 Million
≈ $4.97 Million
€447.92K
≈ $523.67K
0.105x +387.17%
2020-12-31 €3.61 Million
≈ $4.22 Million
€-132.47K
≈ $-154.87K
-0.037x --

About Vytrus Biotech S.A.

MC:VYT Spain Biotechnology
Market Cap
$159.95 Million
€136.82 Million EUR
Market Cap Rank
#19662 Global
#133 in Spain
Share Price
€19.60
Change (1 day)
+0.51%
52-Week Range
€3.04 - €19.80
All Time High
€19.80
About

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. The company offers Clarivine that activates skin's regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Ca… Read more